Targeting of interstitial cells using a simple gene-transfer strategy

Nephrology Dialysis Transplantation

Volumn 21, Issue 10, 2006, Pages 2745-2753

  Fujii, Naohiko ^a   Isaka, Yoshitaka ^a   Takabatake, Yoshitsugu ^a   Mizui, Masayuki ^a   Suzuki, Chigure ^a   Takahara, Shiro ^a   Ito, Takahito ^a   Imai, Enyu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Electroporation; Gene transfer; Interstitial fibroblast; Parenchymal

Indexed keywords

DNA; FLUORESCEIN ISOTHIOCYANATE; FR 901228; HISTONE DEACETYLASE INHIBITOR; INDIAN INK; OLIGODEOXYNUCLEOTIDE; PHOSPHATE BUFFERED SALINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPORATION; EPITHELIUM CELL; EXPRESSION VECTOR; FIBROBLAST; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; INJECTION; KIDNEY BLOOD VESSEL; KIDNEY CORTEX; KIDNEY PARENCHYMA; LEYDIG CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CONNECTIVE TISSUE CELLS; DEPSIPEPTIDES; ELECTROPORATION; FIBROBLASTS; FLUORESCEIN-5-ISOTHIOCYANATE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; KIDNEY; KIDNEY GLOMERULUS; LUCIFERASES; MALE; OLIGODEOXYRIBONUCLEOTIDES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRANSFECTION;

EID: 33749595079     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl327     Document Type: Article

References (16)

1. Risdon R, Sloper J, de Vardener H. Relationship between renal function and histologic changes founf in renal-biopsy spcimens from patients with persistent glomerulonephritis. Lancet 1968; 2: 363-366
2. Maruyama H, Higuchi N, Nishikawa Y et al. Kidney-targeted naked DNA transfer by retrograde renal vein injection in rats. Hum Gene Ther 2002, 13: 455-468
3. Nakamura H, Isaka Y, Tsujie M et al. Introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial alpha-smooth muscle actin expression and fibrosis in unilateral ureteral obstruction (UUO) rats. Gene Ther 2002; 9: 495-502
4. Tsujie M, Isaka Y, Ando Y et al. Gene transfer targeting interstitial fibroblasts by the artificial viral envelope type hemagglutinating virus of Japan liposome method. Kidney Int 2000; 57: 1973-1980
5. Budker V, Budker T, Zhang G et al. Hypothesis: Naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process. J Gene Med 2000; 2: 76-88
6. Lemley K, Kriz W. Structure and function of the renal vasculature with clinical and functional correlations. In: Tisher C, Brenner B, eds. Renal Pathology, Philadelphia: J.B. Lippincott, 1994; 981-1026
7. Grossin L, Cournil-Henrionnet C, Pinzano A et al. Gene transfer with HSP 70 in rat chondrocytes confers cytoprotection in vitro and during experimental osteoarthritis. Faseb J 2006; 20: 65-75
8. Maxwell PH, Ferguson DJ, Nicholls LG et al. The interstitial response to renal injury: Fibroblast-like cells show phenotypic changes and have reduced potential for erythropoietin gene expression. Kidney Int 1997; 52: 715-724
9. Hagstrom JE, Ludtke JJ, Bassik MC et al. Nuclear import of DNA in digitonin-permeabilized cells. J Cell Sci 1997; 110 [Pt 18]: 2323-2331
10. Medi BM, Singh, J. Skin targeted DNA vaccine delivery using electroporation in rabbits II. Safety. Int J Pharm 2005; 294: 53-63
11. Murthy SN, Sen A, Zhao YL et al. Temperature influences the postelectroporation permeability state of the skin. J Pharm Sci 2004; 93: 908-915
12. Oliver JA, Maarouf O, Cheema FH et al. The renal papilla is a niche for adult kidney stem cells. J Clin Invest 2004; 114: 795-804
13. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 1997; 389: 349-352
14. Palmer TD, Rosman GJ, Osborne WR et al. Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc Natl Acad Sci USA 1991; 88: 1330-1334
15. Yamamoto S, Yamano T, Tanaka M et al. A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma. Cancer Gene Ther 2003; 10: 179-186
16. Sandor V, Bakke S, Robey RW et al. Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms. Clin Cancer Res 2002; 8: 718-728